Ipamorelin

NNC 26-0161

Identity

Sequence

Aib-H-(D-2-Nal)-(D-F)-K-NH2

Three-letter

Aib-His-D-2-Nal-D-Phe-Lys-NH₂

Length

5 residues

Modifications

Aib¹; D-2-naphthylalanine³; D-Phe⁴; C-terminal amide

Formula

C38H49N9O5

Average mass

711.9 Da

CAS

170851-70-4

Specifications (per released lot)

Purity

≥ 98 % by RP-HPLC, 220 nm

Identity

ESI-MS; observed mass within 0.1 % of calculated

Form

White to off-white lyophilized powder

Counter-ion

Trifluoroacetate; acetate on request

Net peptide content

Reported per lot (typically 70–90 % of gross mass; the balance is counter-ion and water)

Vial sizes

5 mg · 10 mg · 25 mg net peptide; bulk on quotation

Storage

−20 °C, desiccated, protected from light. Ships at ambient temperature.

Documents

Lot certificate of analysis (COA library); safety data sheet in WHMIS 2015 format, enclosed with every shipment

Research context

Pentapeptide agonist of the growth-hormone secretagogue receptor (GHS-R1a). Used in pituitary-cell and rodent growth-hormone release studies and as a selective ghrelin-receptor reference ligand.

Literature context is provided to help laboratories identify the reagent. It is not a claim about effects in people and does not describe any use outside in-vitro or approved animal research.